This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations

CompletedOBSERVATIONAL

Enrollment

16,746

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 13, 2021

Study Completion Date

July 13, 2021

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Placebo

DRUG

Empagliflozin

Empagliflozin once daily

Trial Locations (1)

Boehringer Ingelheim, Ingelheim